Application and Quality Control Considerations of Immune-Related Recombinant Proteins in Basic Research

I. The Role of Immune-Related Recombinant Proteins in Basic Research

Immune-related recombinant proteins are indispensable tools in basic life science research, particularly in immunology, tumor biology, and the exploration of autoimmune disease mechanisms, where they are commonly used to mimic the in vivo cytokine environment and to activate or inhibit specific signaling pathways. For example, recombinant forms of interleukins (IL-2, IL-6, IL-10, etc.), interferons (IFN-α, IFN-γ), and members of the tumor necrosis factor superfamily (TNF-α, FasL, etc.) are widely used for in vitro culture and functional assays of T cells, B cells, macrophages, and dendritic cells. By adding recombinant proteins at known concentrations, researchers can quantitatively assess indicators such as immune cell proliferation, differentiation, cytokine secretion, and cytotoxicity, thereby elucidating immunoregulatory mechanisms.

II. Key Considerations for Selecting Appropriate Recombinant Proteins

Not all commercially available immune-related recombinant proteins can be directly applied to experimental systems. Researchers need to pay attention to the following parameters:

Expression system: Prokaryotic systems (such as E. coli) offer high expression efficiency but lack glycosylation modifications, making them suitable for cytokines with simple disulfide bond structures; eukaryotic systems (such as CHO cells and HEK293 cells) can provide near-native post-translational modifications, making them suitable for proteins with complex structures or requiring long-chain glycosylation.

Purity and endotoxin levels: Generally, purity ≥95% (SDS-PAGE) and endotoxin ≤1.0 EU/μg are required to avoid nonspecific stimulation of immune cells.

Biological activity validation: High-quality products should be accompanied by EC50 data based on cell proliferation or reporter gene assays, with inter-batch activity variation controlled within a reasonable range.

III. Quality Control: The Cornerstone of Ensuring Experimental Reproducibility

To ensure consistent performance of immune-related recombinant proteins across different batches, manufacturers need to implement strict quality control processes. Common measures include: detecting aggregate content by HPLC-SEC, confirming molecular weight consistency using mass spectrometry (LC-MS/MS), and verifying potency using specific ELISA or functional assays. In addition, the storage stability of the protein (such as activity loss after freeze-thaw cycles) should be analyzed, and recommendations for reconstitution and storage should be provided. Researchers should record batch numbers and operating conditions in detail during use to provide a basis for subsequent data sharing and reproduction.